1. Home
  2. ACLX vs QFIN Comparison

ACLX vs QFIN Comparison

Compare ACLX & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • QFIN
  • Stock Information
  • Founded
  • ACLX 2015
  • QFIN 2016
  • Country
  • ACLX United States
  • QFIN China
  • Employees
  • ACLX N/A
  • QFIN 3527
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • QFIN Finance: Consumer Services
  • Sector
  • ACLX Health Care
  • QFIN Finance
  • Exchange
  • ACLX Nasdaq
  • QFIN Nasdaq
  • Market Cap
  • ACLX 4.4B
  • QFIN 4.0B
  • IPO Year
  • ACLX 2022
  • QFIN 2018
  • Fundamental
  • Price
  • ACLX $88.74
  • QFIN $28.56
  • Analyst Decision
  • ACLX Strong Buy
  • QFIN Strong Buy
  • Analyst Count
  • ACLX 12
  • QFIN 2
  • Target Price
  • ACLX $114.75
  • QFIN $45.10
  • AVG Volume (30 Days)
  • ACLX 515.6K
  • QFIN 1.8M
  • Earning Date
  • ACLX 11-06-2025
  • QFIN 11-18-2025
  • Dividend Yield
  • ACLX N/A
  • QFIN 5.38%
  • EPS Growth
  • ACLX N/A
  • QFIN 68.82
  • EPS
  • ACLX N/A
  • QFIN 7.06
  • Revenue
  • ACLX $56,979,000.00
  • QFIN $2,618,582,596.00
  • Revenue This Year
  • ACLX N/A
  • QFIN $17.67
  • Revenue Next Year
  • ACLX $210.71
  • QFIN $6.25
  • P/E Ratio
  • ACLX N/A
  • QFIN $4.29
  • Revenue Growth
  • ACLX N/A
  • QFIN 9.77
  • 52 Week Low
  • ACLX $47.86
  • QFIN $27.64
  • 52 Week High
  • ACLX $107.37
  • QFIN $48.94
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 68.46
  • QFIN 44.09
  • Support Level
  • ACLX $83.33
  • QFIN $28.29
  • Resistance Level
  • ACLX $89.31
  • QFIN $31.08
  • Average True Range (ATR)
  • ACLX 2.66
  • QFIN 1.29
  • MACD
  • ACLX 0.42
  • QFIN 0.04
  • Stochastic Oscillator
  • ACLX 63.77
  • QFIN 15.00

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About QFIN Qifu Technology Inc.

Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.

Share on Social Networks: